Adrenocortical carcinoma

5 trials 4 recruiting MedDRA PT
5 Registered trials
4 Recruiting
5 Unique sponsors
0 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 5
Phase III: 1 Phase II: 1 Phase I: 3

Filter these 5 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 5 trials

Phase III

1 trial
  • Zealand University Hospital Academic
    IMP not specified
    2022-500013-32-01 3 countries 2024 n=120
    Recruiting

Phase II

1 trial
  • Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Academic
    IMP not specified
    2024-517205-82-00 1 country 2023 n=24
    Ended

Phase I

3 trials
  • BeOne Medicines AG Commercial
    IMP not specified
    2023-506888-34-00 1 country 2024 n=91
    Recruiting
  • Daiichi Sankyo Inc. Commercial
    IMP not specified
    2025-521886-28-00 1 country 2026 n=15
    Recruiting
  • Universitaetsklinikum Wuerzburg AöR Academic
    IMP not specified
    2024-512019-36-00 1 country 2025 n=44
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
BeOne Medicines AG Commercial 1 Phase I 1
Daiichi Sankyo Inc. Commercial 1 Phase I 1
Universitaetsklinikum Wuerzburg AöR Academic 1 Phase I 1
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Academic 1 Phase II 0
Zealand University Hospital Academic 1 Phase III 1
New trials by year
2023
1
2024
2
2025
1
2026
1
← All indication landscapes